Mark Kiel's guest appearances

Mark Kiel

DNA Today: A Genetics Podcast

KGI: Innovation in Applied Life Sciences & Healthcare

Talking Precision Medicine

Barbara Fortini

Atticus Shaffer

Carl Zimmer

Rosalind Franklin

Bonnie Anderson

Keith McArthur

Emily Quinn

David Robinson

Melissa Scott

Adam Rutherford

Julie Walters

Zach Myers

Andrew Wood

Joanne Kamens

Sam Sternberg

OwlTail

In this episode we are exploring the genetics of ALS with Mark Kiel, the Chief Science Officer and Co-Founder of Genomenon. Genomenon is an AI-driven genomics company that keeps pace with the constant advancements made in genomics and connects that research to patient DNA to help diagnose and treat patients with rare genetic diseases and cancer. Mark Kiel completed his M.D., Ph.D., and Molecular Genetic Pathology Fellowship at the University of Michigan, where his research focused on stem cell biology, genomic profiling of hematopoietic malignancies, and clinical bioinformatics. He is the founder and CSO of Genomenon, where he oversees the company’s scientific direction and product development. Mark has extensive experience in genome-sequencing and clinical data analysis. On This Episode We Discuss:Overview of ALSHow ALS is diagnosedCauses of ALSGenetic testing for pathogenic variants Expansion of the list of causative genes and variants for ALSUncovered trends in age at onset and rate of progressionNew data on the prevalence of gene mutations in ALSValidation of the novel utility of the genomic landscape for ALSTo learn more about Genomenon and the findings from their comprehensive Genomic Landscape for ALS, visit their website, or check them out on Twitter and LinkedIn. Stay tuned for the next new episode of DNA Today on October 15th where we welcome Erika Stallings and Dena Goldberg to discuss the organization, Black Cancer Genes, in honor of breast cancer awareness month! New episodes are released on the first and third Friday of the month. In the meantime, you can binge over 150 other episodes on Apple Podcasts, Spotify, streaming on the website, or any other podcast player by searching, “DNA Today”. Episodes in 2021 are also recorded with video which you can watch on our YouTube channel.  See what else we are up to on Twitter, Instagram, Facebook, YouTube and our website, DNApodcast.com. Questions/inquiries can be sent to info@DNApodcast.com.Do you or someone you know have Prader-Willi syndrome? Harmony Biosciences is looking for people with Prader-Willi syndrome to enroll in a new clinical study in the United States. Harmony Biosciences will be studying the safety and impact of an investigational medication on excessive daytime sleepiness, cognition, and behavioral function in people with Prader Willi syndrome. Learn more about the clinical study and refer a patient to a study center here. (SPONSORED)Do you work in a lab? Want to receive rewards when you order supplies? Check out Thermo Fisher Scientific’s Aspire program, it’s a rewards program created with scientists, like you, in mind. All members receive a free full size trial product every year. Points are earned every time you use or purchase products. Rewards include science themed apparel like a zip up DNA hoodie! Check it out at ThermoFisher.com/aspire-DNAtoday and for a limited time receive 500 bonus points. See the show notes for terms and conditions and that link. Terms and Conditions: Open only to eligible participants in the US (excluding Puerto Rico) and Canada (excluding Quebec). Eligible participants must complete the enrollment process for the Aspire member program in order to be enrolled in the program and receive rewards and benefits. Enrollees must confirm their health care professional or government employment status during time of enrollment. For full terms and conditions of the program, go to thermofisher.com/aspire/tc. Offer is void where prohibited, licensed, or restricted by federal, state, provincial, or local laws or regulation or agency/institutional policy. Other restrictions may apply. (SPONSORED)

In this episode we are exploring the genetics of ALS with Mark Kiel, the Chief Science Officer and Co-Founder of <a href="https://www.genomenon.com/about/" rel="nofollow" target="_blank">Genomenon</a>. Genomenon is an AI-driven genomics company that keeps pace with the constant advancements made in genomics and connects that research to patient DNA to help diagnose and treat patients with rare genetic diseases and cancer.  Mark Kiel completed his M.D., Ph.D., and Molecular Genetic Pathology Fellowship at the University of Michigan, where his research focused on stem cell biology, genomic profiling of hematopoietic malignancies, and clinical bioinformatics. He is the founder and CSO of Genomenon, where he oversees the company’s scientific direction and product development. Mark has extensive experience in genome-sequencing and clinical data analysis.  On This Episode We Discuss:Overview of ALSHow ALS is diagnosedCauses of ALSGenetic testing for pathogenic variants Expansion of the list of causative genes and variants for ALSUncovered trends in age at onset and rate of progressionNew data on the prevalence of gene mutations in ALSValidation of the novel utility of the genomic landscape for ALS To learn more about Genomenon and the findings from their comprehensive Genomic Landscape for ALS, visit their <a href="https://www.genomenon.com/" rel="nofollow" target="_blank">website</a>, or check them out on <a href="https://twitter.com/genomenon" rel="nofollow" target="_blank">Twitter</a> and <a href="https://www.linkedin.com/company/genomenon/" rel="nofollow" target="_blank">LinkedIn</a>.  Stay tuned for the next new episode of DNA Today on October 15th where we welcome Erika Stallings and Dena Goldberg to discuss the organization, Black Cancer Genes, in honor of breast cancer awareness month! New episodes are released on the first and third Friday of the month. In the meantime, you can binge over 150 other episodes on <a href="https://itunes.apple.com/us/podcast/dna-today-a-genetics-podcast/id1209263436?mt=2" rel="nofollow" target="_blank">Apple Podcasts</a>, <a href="https://open.spotify.com/show/2TbRJMsOOeUTphJTqIYc6E?si=L-TO3D2HRJquTp1fCiVBbg" rel="nofollow" target="_blank">Spotify</a>, <a href="http://dnapodcast.com" rel="nofollow" target="_blank">streaming on the website</a>, or any other podcast player by searching, “DNA Today”. Episodes in 2021 are also recorded with video which you can watch on <a href="https://www.youtube.com/channel/UCj5c3YSE2zMDaP4ATMrvKbg?view_as=subscriber" rel="nofollow" target="_blank">our YouTube channel</a>.   See what else we are up to on <a href="https://twitter.com/DNApodcast" rel="nofollow" target="_blank">Twitter</a>, <a href="https://www.instagram.com/dnaradio/" rel="nofollow" target="_blank">Instagram</a>, <a href="https://www.facebook.com/DNApodcast/" rel="nofollow" target="_blank">Facebook</a>, <a href="https://www.youtube.com/channel/UCj5c3YSE2zMDaP4ATMrvKbg?view_as=subscriber" rel="nofollow" target="_blank">YouTube</a> and our website, <a href="http://dnapodcast.com/" rel="nofollow" target="_blank">DNApodcast.com</a>. Questions/inquiries can be sent to <a href="mailto:info@DNApodcast.com">info@DNApodcast.com</a>.Do you or someone you know have Prader-Willi syndrome? Harmony Biosciences is looking for people with Prader-Willi syndrome to enroll in a new clinical study in the United States. Harmony Biosciences will be studying the safety and impact of an investigational medication on excessive daytime sleepiness, cognition, and behavioral function in people with Prader Willi syndrome. Learn more about the clinical study and refer a patient to a study center<a href="https://knowrare.com/hcp-referral-for-harmony-pws-study" rel="nofollow" target="_blank"> here.</a> (SPONSORED)Do you work in a lab? Want to receive rewards when you order supplies? Check out Thermo Fisher Scientific’s Aspire program, it’s a rewards program created with scientists, like you, in mind. All members receive a free full size trial product every year. Points are earned every time you use or purchase products. Rewards include science themed apparel like a zip up DNA hoodie! Check it out at <a href="http://thermofisher.com/aspire-dnatoday" rel="nofollow" target="_blank">ThermoFisher.com/aspire-DNAtoday</a> and for a limited time receive 500 bonus points. See the show notes for terms and conditions and that link.  Terms and Conditions: Open only to eligible participants in the US (excluding Puerto Rico) and Canada (excluding Quebec). Eligible participants must complete the enrollment process for the Aspire member program in order to be enrolled in the program and receive rewards and benefits. Enrollees must confirm their health care professional or government employment status during time of enrollment. For full terms and conditions of the program, go to <a href="http://thermofisher.com/aspire/tc" rel="nofollow" target="_blank">thermofisher.com/aspire/tc</a>. Offer is void where prohibited, licensed, or restricted by federal, state, provincial, or local laws or regulation or agency/institutional policy. Other restrictions may apply. (SPONSORED)

#158 Mark Kiel on ALS Genetics

In Talking Precision Medicine podcast we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine. This show is brought to you by Genialis, and Rafael, our CEO, is your host.  Genialis is focused on data integration and predictive modeling of disease biology to help accelerate the discovery and de-risk the development of novel therapeutics.   Today we speak with Mark Kiel. Mark is the founder and Chief Scientific Officer at Genomenon where he shepherds the product vision and implementation of the Mastermind suite of software tools. He completed an MD / PhD  fellowship in Molecular Genetic Pathology at the University of Michigan.  In this episode, Mark describes the genesis of his vision to organize the world’s molecular data and his journey to realize the promise of genomic medicine.

In Talking Precision Medicine podcast we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine. This show is brought to you by Genialis, and Rafael, our CEO, is your host.  Genialis is focused on data integration and predictive modeling of disease biology to help accelerate the discovery and de-risk the development of novel therapeutics.  Today we speak with Mark Kiel. Mark is the founder and Chief Scientific Officer at Genomenon where he shepherds the product vision and implementation of the Mastermind suite of software tools. He completed an MD / PhD  fellowship in Molecular Genetic Pathology at the University of Michigan.  In this episode, Mark describes the genesis of his vision to organize the world’s molecular data and his journey to realize the promise of genomic medicine.

Organizing the world’s variant data for genomic medicine with Mark Kiel | Talking Precision Medicine #12

Today's episode features Mark Kiel, the CSO and Co-Founder at Genomenon! The show host is Barbara Fortini, an assistant professor of genetics in the Keck Graduate Institute (KGI) School of Pharmacy and Health Sciences and the Master of Science in Human Genetics and Genomic Data Analytics (MSGDA) program coordinator. KGI has become the first academic partner in a new genomics education program launched by Genomenon, creator of the Mastermind genomic search engine providing search results from the full-text database of 6.5 million genomic-focused scientific articles. “We feel strongly that Mastermind is the best way to interpret variants and make clinical decisions more quickly. We realized that schools like KGI are the future of genomics. We’re partners in equipping the next generation of genomic scientists,” says Candace Chapman, director of marketing for Genomenon, a privately held company founded in Ann Arbor, Michigan, in 2014. Fortini adds, “It is a meeting of the minds. Genomenon is interested in making relevant products to understand variation in the human genome. KGI is interested in revolutionizing education and is the first of its kind to educate students for evolving roles in clinical genomics and genetic counseling.” Here are a few different links and resources mentioned in this interview:  Mark's Comeback Story Sign up for the Mastermind Genomic Search Engine (Basic Edition is free) Genomenon's Variant Interpretation Cards 

Today's episode features <a href="https://www.linkedin.com/in/mark-kiel-4836006b/" rel="nofollow" target="_blank">Mark Kiel</a>, the CSO and Co-Founder at <a href="https://www.genomenon.com" rel="nofollow" target="_blank">Genomenon</a>! The show host is <a href="https://www.kgi.edu/people/barbara-kraatz-fortini/" rel="nofollow" target="_blank">Barbara Fortini</a>, an assistant professor of genetics in the Keck Graduate Institute (KGI) School of Pharmacy and Health Sciences and the <a href="https://www.kgi.edu/msgda" rel="nofollow" target="_blank">Master of Science in Human Genetics and Genomic Data Analytics</a> (MSGDA) program coordinator. KGI has become the first academic partner in a new genomics education program launched by Genomenon, creator of the Mastermind genomic search engine providing search results from the full-text database of 6.5 million genomic-focused scientific articles. “We feel strongly that Mastermind is the best way to interpret variants and make clinical decisions more quickly. We realized that schools like KGI are the future of genomics. We’re partners in equipping the next generation of genomic scientists,” says Candace Chapman, director of marketing for Genomenon, a privately held company founded in Ann Arbor, Michigan, in 2014. Fortini adds, “It is a meeting of the minds. Genomenon is interested in making relevant products to understand variation in the human genome. KGI is interested in revolutionizing education and is the first of its kind to educate students for evolving roles in clinical genomics and genetic counseling.” Here are a few different links and resources mentioned in this interview: <ul> <li><a href="https://www.genomenon.com/blog/startupstorynight2019/" rel="nofollow" target="_blank">Mark's Comeback Story</a></li> <li><a href="https://mastermind.genomenon.com/users/sign_up/?ref=kgi" rel="nofollow" target="_blank">Sign up for the Mastermind Genomic Search Engine (Basic Edition is free)</a></li> <li><a href="https://www.genomenon.com/cards/" rel="nofollow" target="_blank">Genomenon's Variant Interpretation Cards</a></li> </ul>

#73 - Mark Kiel